HBK Sorce Advisory’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $545K | Buy |
7,803
+92
| +1% | +$6.43K | 0.01% | 322 |
|
|
2025
Q1 | $567K | Buy |
7,711
+23
| +0.3% | +$1.69K | 0.02% | 310 |
|
|
2024
Q4 | $504K | Sell |
7,688
-437
| -5% | -$28.6K | 0.02% | 333 |
|
|
2024
Q3 | $633K | Sell |
8,125
-703
| -8% | -$54.8K | 0.02% | 288 |
|
|
2024
Q2 | $688K | Buy |
8,828
+330
| +4% | +$25.7K | 0.02% | 269 |
|
|
2024
Q1 | $576K | Buy |
8,498
+196
| +2% | +$13.3K | 0.02% | 308 |
|
|
2023
Q4 | $559K | Sell |
8,302
-85
| -1% | -$5.73K | 0.02% | 293 |
|
|
2023
Q3 | $568K | Buy |
8,387
+47
| +0.6% | +$3.18K | 0.03% | 285 |
|
|
2023
Q2 | $597K | Sell |
8,340
-171
| -2% | -$12.2K | 0.03% | 288 |
|
|
2023
Q1 | $591K | Sell |
8,511
-9,375
| -52% | -$651K | 0.03% | 292 |
|
|
2022
Q4 | $1.21M | Buy |
17,886
+4,565
| +34% | +$310K | 0.03% | 254 |
|
|
2022
Q3 | $672K | Buy |
13,321
+1,969
| +17% | +$99.3K | 0.05% | 210 |
|
|
2022
Q2 | $750K | Sell |
11,352
-3,067
| -21% | -$203K | 0.06% | 190 |
|
|
2022
Q1 | $957K | Sell |
14,419
-3,971
| -22% | -$264K | 0.05% | 204 |
|
|
2021
Q4 | $1.07M | Buy |
18,390
+343
| +2% | +$20K | 0.05% | 205 |
|
|
2021
Q3 | $1.08M | Buy |
18,047
+2,151
| +14% | +$129K | 0.06% | 196 |
|
|
2021
Q2 | $952K | Buy |
15,896
+2,852
| +22% | +$171K | 0.05% | 205 |
|
|
2021
Q1 | $649K | Sell |
13,044
-1,466
| -10% | -$72.9K | 0.04% | 250 |
|
|
2020
Q4 | $725K | Sell |
14,510
-2,548
| -15% | -$127K | 0.04% | 224 |
|
|
2020
Q3 | $935K | Sell |
17,058
-2,794
| -14% | -$153K | 0.07% | 181 |
|
|
2020
Q2 | $1.05M | Buy |
19,852
+13,385
| +207% | +$708K | 0.08% | 165 |
|
|
2020
Q1 | $289K | Buy |
6,467
+1,522
| +31% | +$68K | 0.03% | 298 |
|
|
2019
Q4 | $247K | Buy |
+4,945
| New | +$247K | 0.02% | 372 |
|
|
2018
Q2 | – | Sell |
-6,066
| Closed | -$212K | – | 390 |
|
|
2018
Q1 | $212K | Sell |
6,066
-240
| -4% | -$8.39K | 0.03% | 343 |
|
|
2017
Q4 | $219K | Buy |
+6,306
| New | +$219K | 0.03% | 352 |
|